Greetings Colleagues,

We wish you, our esteemed readers and contributors, a happy New Year from all of us here at Cancer Prevention Research (CaPR). It is my pleasure to report on the state of the journal after a very productive and rewarding 2013. As Editor-in-Chief, I am proud of the fact that the journal continues to publish high quality primary papers, perspectives, minireviews and commentaries from clinical and preclinical disciplines within our diverse scope—all helping to shape the field of prevention.

In late 2012, we published a groundbreaking study that validated loss of heterozygosity (LOH) profiles in predicting risk of progression to oral cancer in patients with low-grade oral dysplasia (1–3). Building on this and more recent work in the molecular study of premalignancy (4, 5), CaPR senior editor Ignacio Wistuba is heading a new minireview series focused on the early pathogenesis of selected...

You do not currently have access to this content.